Dactinomycin in acute myeloid leukemia with NPM1 mutations.

Abstract excerpt

OBJECTIVES: Complete responses have been observed in NPM1-mutated AML patients with dactinomycin, a nucleolar stress-inducing drug. Here, we report a single-center experience of compassionate use of dactinomycin in untreated or relapsed/ refractory NPM1-mutated AML. METHODS: From September 2015 to February 2019, 26 adult patients with NPM1-mutated AML received dactinomycin in different situations: front-line...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antibiotics, Antineoplastic
• Share to Dactinomycin